Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes - PubMed (original) (raw)

. 1996 Aug-Sep;354(3):262-7.

doi: 10.1007/BF00171056.

Affiliations

• PMID: 8878055
• DOI: 10.1007/BF00171056

Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes

B B Fredholm et al. Naunyn Schmiedebergs Arch Pharmacol. 1996 Aug-Sep.

Abstract

Using the reverse transcription polymerase chain reaction (RT-PCR) we found that human neutrophils express mRNA for both A2A and A2B adenosine receptors, and using selective adenosine receptor agonists and antagonists we have characterized the type of adenosine receptor mediating inhibition of formyl-Met-Leu-Phe (fMLP)-induced oxidative burst. The order of potency of agonists was 5'-N-ethyl-carboxamidoadenosine (NECA) > 2-phenylaminoadenosine > 2-[p-(2-carbonyl-ethyl)-phenyl-ethylamino]-5'-N-ethyl-carboxamido adenosine (CGS 21680) > adenosine > N6-cyclopentyl-adenosine. This agrees with the agonist potency at human A2A receptors. The effect of adenosine was antagonized by 30 microM theophylline > caffeine = paraxanthine, i.e. concentrations close to those occurring in plasma after consumption of caffeine-containing beverages. The effect of NECA was unaltered by the A1 receptor antagonist 1,3-dipropyl-8-cyclopentylxanthine, but inhibited by the A2A receptor selective antagonists 4-amino-8-chloro-1-phenyl-[1,2,4]-triazolo[4,3-a]quinoxaline (CP 66,713), 1,3-dipropyl-8-(3,4-dimethoxystyryl) -7-methylxanthine (KF 17387) and 8-(3-chlorostyryl)caffeine as well as by the non-selective, non-xanthine antagonist 5-amino-9-chloro-2-(2-furyl)-[1,2,4]-triazolo-[1,5-c]quinazoline methane sulphonate (CGS 15943). The adenosine receptor mediated responses were antagonized by the protein kinase A blocker Rp-cyclic adenosine 3',5'-phosphorothioate (Rp-cAMP). In conclusion, the adenosine-induced inhibition of neutrophil activation is mediated by adenosine A2A receptors.

PubMed Disclaimer

Similar articles

• Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
  Zocchi C, Ongini E, Ferrara S, Baraldi PG, Dionisotti S. Zocchi C, et al. Br J Pharmacol. 1996 Apr;117(7):1381-6. doi: 10.1111/j.1476-5381.1996.tb15296.x. Br J Pharmacol. 1996. PMID: 8730729 Free PMC article.
• Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
  Patel M, Sheehan MJ, Strong P. Patel M, et al. Br J Pharmacol. 1994 Nov;113(3):741-8. doi: 10.1111/j.1476-5381.1994.tb17056.x. Br J Pharmacol. 1994. PMID: 7858863 Free PMC article.
• Propentofylline enhancement of the actions of adenosine on neutrophil leukocytes.
  Zhang Y, Fredholm BB. Zhang Y, et al. Biochem Pharmacol. 1994 Nov 29;48(11):2025-32. doi: 10.1016/0006-2952(94)90501-0. Biochem Pharmacol. 1994. PMID: 7802691
• The role of the adenosinergic system in lung fibrosis.
  Della Latta V, Cabiati M, Rocchiccioli S, Del Ry S, Morales MA. Della Latta V, et al. Pharmacol Res. 2013 Oct;76:182-9. doi: 10.1016/j.phrs.2013.08.004. Epub 2013 Aug 28. Pharmacol Res. 2013. PMID: 23994158 Review.
• Molecular and Structural Insight into Adenosine A2A Receptor in Neurodegenerative Disorders: A Significant Target for Efficient Treatment Approach.
  Karati D, Mukherjee S, Roy S. Karati D, et al. Mol Neurobiol. 2023 Oct;60(10):5987-6000. doi: 10.1007/s12035-023-03441-5. Epub 2023 Jun 30. Mol Neurobiol. 2023. PMID: 37391647 Review.

Cited by

• OppA, the ecto-ATPase of Mycoplasma hominis induces ATP release and cell death in HeLa cells.
  Hopfe M, Henrich B. Hopfe M, et al. BMC Microbiol. 2008 Apr 4;8:55. doi: 10.1186/1471-2180-8-55. BMC Microbiol. 2008. PMID: 18394151 Free PMC article.
• Role of adenosine A(2B) receptors in inflammation.
  Feoktistov I, Biaggioni I. Feoktistov I, et al. Adv Pharmacol. 2011;61:115-44. doi: 10.1016/B978-0-12-385526-8.00005-9. Adv Pharmacol. 2011. PMID: 21586358 Free PMC article. Review.
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
  Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. Fredholm BB, et al. Pharmacol Rev. 2001 Dec;53(4):527-52. Pharmacol Rev. 2001. PMID: 11734617 Free PMC article. Review.
• A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli.
  Csóka B, Németh ZH, Virág L, Gergely P, Leibovich SJ, Pacher P, Sun CX, Blackburn MR, Vizi ES, Deitch EA, Haskó G. Csóka B, et al. Blood. 2007 Oct 1;110(7):2685-95. doi: 10.1182/blood-2007-01-065870. Epub 2007 May 24. Blood. 2007. PMID: 17525287 Free PMC article.
• Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.
  Alencar AKN, Montes GC, Barreiro EJ, Sudo RT, Zapata-Sudo G. Alencar AKN, et al. Front Pharmacol. 2017 Dec 4;8:858. doi: 10.3389/fphar.2017.00858. eCollection 2017. Front Pharmacol. 2017. PMID: 29255415 Free PMC article. Review.

References

1. 1. Circulation. 1992 Sep;86(3):986-94 - PubMed
2. 1. Biochem Biophys Res Commun. 1992 Aug 31;187(1):86-93 - PubMed
3. 1. Anal Biochem. 1987 Sep;165(2):371-8 - PubMed
4. 1. Trends Pharmacol Sci. 1992 Dec;13(12):439-45 - PubMed
5. 1. J Immunol. 1987 Mar 15;138(6):1896-903 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Miscellaneous

  • NCI CPTAC Assay Portal